INTECH Investment Management’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$636K Sell
14,829
-2,233
-13% -$83.2K 0.01% 1239
2026
Q1
$686K Sell
17,062
-776
-4% -$33.4K 0.01% 1184
2025
Q4
$903K Buy
17,838
+424
+2% +$15.1K 0.01% 1184
2025
Q3
$506K Sell
17,414
-12,125
-41% -$280K ﹤0.01% 1573
2025
Q2
$696K Buy
29,539
+893
+3% +$20.1K 0.01% 1420
2025
Q1
$688K Buy
28,646
+11,576
+68% +$372K 0.01% 1436
2024
Q4
$722K Buy
17,070
+6,333
+59% +$280K 0.01% 1342
2024
Q3
$475K Buy
+10,737
New +$407K 0.01% 1254

Other funds holding VERA

INTECH Investment Management's VERA Position: Q2 2026 in Review

INTECH Investment Management reduced its Vera Therapeutics (VERA) stake by 13% in Q2 2026, selling an estimated $83.2K and leaving 14,829 shares worth $636K. The position accounts for 0.01% of the portfolio, ranked #1239.

INTECH Investment Management first reported a position in VERA in Q3 2024 and has held it in 8 quarters since. The position peaked at $903K in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • INTECH Investment Management held 14,829 shares of Vera Therapeutics worth $636K as of Q2 2026.
  • INTECH Investment Management sold 2,233 Vera Therapeutics shares in Q2 2026, an estimated $83.2K.
  • Vera Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1239 holding.
  • INTECH Investment Management first reported a position in Vera Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Vera Therapeutics position peaked at $903K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.